Literature DB >> 21191674

The role of anxiety and emotional stress as a risk factor in treatment-resistant hypertension.

Michael Greenage1, Burak Kulaksizoglu, Mehmet Cilingiroglu, Rizwan Ali.   

Abstract

Depression and anxiety are both known to be co-morbid with coronary heart disease. Given the high prevalence of coronary heart disease today, specifically the aspect of hypertension, it seems more important than ever to investigate whether or not treatment of these co-morbidities can have an effect on reducing hypertension. This article summarizes the limited amount of literature that has been published in this area and highlights what we believe to be a missing key element that will guide our own future research in this area.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21191674     DOI： 10.1007/s11883-010-0154-z

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


  8 in total

Review 1.  Essential hypertension. Part I: definition and etiology.

Authors:  O A Carretero; S Oparil
Journal:  Circulation       Date:  2000-01-25       Impact factor: 29.690

2.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men.

Authors:  Imre Janszky; Staffan Ahnve; Ingvar Lundberg; Tomas Hemmingsson
Journal:  J Am Coll Cardiol       Date:  2010-06-29       Impact factor: 24.094

4.  Ambulatory blood pressure monitoring in patients with panic disorder.

Authors:  W B White; L H Baker
Journal:  Arch Intern Med       Date:  1987-11

5.  Panic disorder, anxiety and depression in resistant hypertension--a case-control study.

Authors:  S J Davies; P Ghahramani; P R Jackson; J Hippisley-Cox; W W Yeo; L E Ramsay
Journal:  J Hypertens       Date:  1997-10       Impact factor: 4.844

Review 6.  Depression and the course of coronary artery disease.

Authors:  A H Glassman; P A Shapiro
Journal:  Am J Psychiatry       Date:  1998-01       Impact factor: 18.112

Review 7.  Panic disorder and somatization. Review of 55 cases.

Authors:  W Katon
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

8.  Episodic hypertension secondary to panic disorder.

Authors:  W B White; L H Baker
Journal:  Arch Intern Med       Date:  1986-06
  8 in total
  3 in total

1.  Lessons learned from a study of a complementary therapy for self-managing hypertension and stress in women.

Authors:  Kikikipa Kretzer; Andrew J Evelo; Robert L Durham
Journal:  Holist Nurs Pract       Date:  2013 Nov-Dec       Impact factor: 1.000

2.  Associations between mental disorders and subsequent onset of hypertension.

Authors:  Dan J Stein; Sergio Aguilar-Gaxiola; Jordi Alonso; Ronny Bruffaerts; Peter de Jonge; Zharoui Liu; Jose Miguel Caldas-de-Almeida; Siobhan O'Neill; Maria Carmen Viana; Ali Obaid Al-Hamzawi; Mattias C Angermeyer; Corina Benjet; Ron de Graaf; Finola Ferry; Viviane Kovess-Masfety; Daphna Levinson; Giovanni de Girolamo; Silvia Florescu; Chiyi Hu; Norito Kawakami; Josep Maria Haro; Marina Piazza; Jose Posada-Villa; Bogdan J Wojtyniak; Miguel Xavier; Carmen C W Lim; Ronald C Kessler; Kate M Scott
Journal:  Gen Hosp Psychiatry       Date:  2013-11-14       Impact factor: 3.238

3.  Addition of Propranolol in Resistant Arterial hypertension Treatment (APROPRIATE study): study protocol for a randomized double-blind placebo-controlled trial.

Authors:  G R Constantine; P Ranasinghe; P Weeratunga; C Weeraratne; P Galappatthy; S Rajapakse; U Senarath; P Katulanda
Journal:  Trials       Date:  2017-03-14       Impact factor: 2.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.